• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Role of Anti-SSB/La Antibodies as Predictors of Decreased Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO) in Primary Sjögren Disease.抗SSB/La抗体作为原发性干燥综合征患者肺一氧化碳弥散量(DLCO)降低预测指标的作用
Int J Mol Sci. 2025 Jun 19;26(12):5867. doi: 10.3390/ijms26125867.
2
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.环磷酰胺用于治疗结缔组织病相关的间质性肺疾病。
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
3
Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.干燥综合征患者泪液中的抗Ro/SSA和抗La/SSB自身抗体。
Br J Ophthalmol. 2004 Mar;88(3):384-7. doi: 10.1136/bjo.2003.028340.
4
Long-term clinical prognosis of anti-aminoacyl-tRNA synthetase antibodies and interstitial lung disease.抗氨酰-tRNA合成酶抗体与间质性肺疾病的长期临床预后
Clin Rheumatol. 2025 Jun 27. doi: 10.1007/s10067-025-07521-w.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?吸烟患者中局灶性唇涎腺炎的发生率较低(灶性评分)。从组织学检查以及干燥综合征患者的抗SSA/Ro和抗SSB/La抗体判断,烟草会减轻唾液腺受累情况吗?
Ann Rheum Dis. 2000 Jan;59(1):54-60. doi: 10.1136/ard.59.1.54.
7
Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.原发性干燥综合征伴或不伴雷诺现象及抗SSA/Ro和抗SSB/La抗体阳性时的甲襞毛细血管镜检查结果
Rheumatol Int. 2016 Mar;36(3):365-9. doi: 10.1007/s00296-015-3396-9. Epub 2015 Nov 23.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Thoracic imaging tests for the diagnosis of COVID-19.用于 COVID-19 诊断的胸部影像学检查。
Cochrane Database Syst Rev. 2022 May 16;5(5):CD013639. doi: 10.1002/14651858.CD013639.pub5.
10
TAFRO syndrome: A severe manifestation of Sjogren's syndrome? A systematic review.TAFRO 综合征:干燥综合征的严重表现?系统综述。
Autoimmun Rev. 2022 Aug;21(8):103137. doi: 10.1016/j.autrev.2022.103137. Epub 2022 Jul 6.

本文引用的文献

1
Interstitial Lung Disease in Primary Sjögren's Syndrome: Risk factors for occurrence and radiographic progression.原发性干燥综合征中的间质性肺疾病:发生及影像学进展的危险因素
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Sep 24;41(3):e2024035. doi: 10.36141/svdld.v41i3.15548.
2
Screening, diagnosis, and monitoring of interstitial lung disease in autoimmune rheumatic diseases: A narrative review.自身免疫性风湿性疾病中间质性肺疾病的筛查、诊断及监测:一篇叙述性综述
Rev Colomb Reumatol. 2024 Apr;31(Suppl 1):S3-S14. doi: 10.1016/j.rcreu.2023.06.002. Epub 2023 Aug 26.
3
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome.原发性干燥综合征患者中进行性纤维化间质性肺疾病的患病率
J Pers Med. 2024 Jul 1;14(7):708. doi: 10.3390/jpm14070708.
4
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.2023 年美国风湿病学会(ACR)/美国胸科学会(CHEST)系统性自身免疫性风湿病患者间质性肺病筛查和监测指南。
Arthritis Rheumatol. 2024 Aug;76(8):1201-1213. doi: 10.1002/art.42860. Epub 2024 Jul 8.
5
The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies.抗 SSA/SSB 和 Ro52 抗体在特发性炎性肌病中对临床表型的差异作用。
Semin Arthritis Rheum. 2024 Apr;65:152407. doi: 10.1016/j.semarthrit.2024.152407. Epub 2024 Feb 8.
6
Manifestations and management of Sjögren's disease.干燥综合征的表现与治疗。
Arthritis Res Ther. 2024 Feb 8;26(1):43. doi: 10.1186/s13075-024-03262-4.
7
The Spectrum of Extraglandular Manifestations in Primary Sjögren's Syndrome.原发性干燥综合征的腺体外表现谱
J Pers Med. 2023 Jun 7;13(6):961. doi: 10.3390/jpm13060961.
8
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.原发性干燥综合征中的间质性肺疾病和肺损伤:一项系统评价和荟萃分析
J Clin Med. 2023 Mar 29;12(7):2586. doi: 10.3390/jcm12072586.
9
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis.结缔组织病相关性间质性肺疾病的流行情况、影像学表现及危险因素:系统评价和荟萃分析。
Eur Respir Rev. 2023 Mar 8;32(167). doi: 10.1183/16000617.0210-2022. Print 2023 Mar 31.
10
Pulmonary fibrosis in primary Sjögren syndrome: computed tomography, clinical features, and associated clinical factors.原发性干燥综合征中的肺纤维化:计算机断层扫描、临床特征及相关临床因素
Pol Arch Intern Med. 2023 Feb 27;133(2). doi: 10.20452/pamw.16394. Epub 2023 Jan 4.

抗SSB/La抗体作为原发性干燥综合征患者肺一氧化碳弥散量(DLCO)降低预测指标的作用

The Role of Anti-SSB/La Antibodies as Predictors of Decreased Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO) in Primary Sjögren Disease.

作者信息

Caraiola Simona, Voicu Laura, Opriș-Belinski Daniela, Cobilinschi Claudia Oana, Pârvu Magda Ileana, Ion Ion Andrei, Gologanu Daniela Ștefana, Ionescu Răzvan Adrian

机构信息

Fifth Department-Internal Medicine (Cardiology, Gastroenterology, Hepatology, Rheumatology, Geriatrics), Family Medicine, Occupational Medicine, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Internal Medicine Department, Colentina Clinical Hospital, 020125 Bucharest, Romania.

出版信息

Int J Mol Sci. 2025 Jun 19;26(12):5867. doi: 10.3390/ijms26125867.

DOI:10.3390/ijms26125867
PMID:40565330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12192972/
Abstract

Lung involvement is the most common extraglandular manifestation of primary Sjögren's Disease (pSjD). There is an increasing interest in finding the clinical/serological risk predictors of this feature. A cross-sectional study evaluating anti-SSA/Ro antibodies, anti-SSB/La antibodies, rheumatoid factor, antinuclear antibodies, and the diffusing capacity of the lungs for carbon monoxide (DLCO) in 26 pSjD patients who presented interstitial changes on the chest CT scan was performed. The titres and positivity rates for anti-SSA/Ro ( = 0.02, = 0.02) and anti-SSB/La antibodies ( = 0.01, = 0.001) proved to be significantly increased in patients with abnormal DLCO. Anti-SSB/La antibodies' titres seemed to be the best predictor for decreased DLCO-AUC 0.791 (0.587-0.994), = 0.016. A close-to-significance decrease was found in the titres ( = 0.07) and positivity rates- = 0.09 and OR of 0.15 (0.01-1.63)-of anti-SSB/La antibodies in patients with usual interstitial pneumonia (UIP), indicating their possible protective role against UIP. The lymphocytic interstitial pneumonitis (LIP) pattern on lung CT scan was significantly associated with the simultaneous positivity of the four examined serological markers ( = 0.03). The increase in anti-SSB/La antibody positivity rate in patients with LIP patterns was situated close to the significance level ( = 0.09). Quadruple positivity, as well as isolated anti-SSB/La positivity, could be risk factors for developing LIP in pSjD patients. Thus, anti-SSB/La antibodies might represent a marker of lung involvement in pSjD patients.

摘要

肺部受累是原发性干燥综合征(pSjD)最常见的腺外表现。人们对寻找这一特征的临床/血清学风险预测指标的兴趣与日俱增。对26例胸部CT扫描显示有间质性改变的pSjD患者进行了一项横断面研究,评估抗SSA/Ro抗体、抗SSB/La抗体、类风湿因子、抗核抗体以及肺一氧化碳弥散量(DLCO)。结果显示,DLCO异常的患者中,抗SSA/Ro(P = 0.02,OR = 0.02)和抗SSB/La抗体(P = 0.01,OR = 0.001)的滴度和阳性率显著升高。抗SSB/La抗体滴度似乎是DLCO降低的最佳预测指标——AUC为0.791(0.587 - 0.994),P = 0.016。在寻常型间质性肺炎(UIP)患者中,抗SSB/La抗体的滴度(P = 0.07)和阳性率(P = 0.09,OR为0.15(0.01 - 1.63))有接近显著的下降,表明它们可能对UIP有保护作用。肺部CT扫描显示的淋巴细胞间质性肺炎(LIP)模式与所检测的四种血清学标志物同时呈阳性显著相关(P = 0.03)。LIP模式患者中抗SSB/La抗体阳性率的升高接近显著水平(P = 0.09)。四重阳性以及单独的抗SSB/La阳性可能是pSjD患者发生LIP的危险因素。因此,抗SSB/La抗体可能是pSjD患者肺部受累的一个标志物。